Back
Day Range
$17.39
$17.96
52-Week Range
$16.10
$30.48
Volume
1,768,591
50D / 200D Avg
$21.38
/
$22.48
Prev Close
$17.23
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 101.2 | 0.2 |
| P/B | 6.1 | 3.0 |
| ROE % | 7.5 | 3.6 |
| Net Margin % | 2.2 | 3.8 |
| Rev Growth 5Y % | 97.1 | 9.9 |
| D/E | 1.3 | 0.2 |
Analyst Price Target
Hold
$33.50
+89.1%
Low: $19.00
High: $52.00
Forward EPS
-$1.12
Est. Revenue
861.52M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.48
$2.15 – $2.80
|
1.54B | 8 |
| FY2029 |
$1.50
$1.30 – $1.70
|
1.37B | 10 |
| FY2028 |
$1.18
-$0.93 – $7.96
|
1.26B | 18 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | -$0.37 | -$0.47 | -25.7% |
| 2025-10-30 | $1.03 | $1.67 | +62.1% |
| 2025-07-31 | -$0.44 | -$0.33 | +25.0% |
| 2025-05-07 | -$0.36 | -$0.74 | -105.6% |
| 2025-02-28 | -$0.37 | -$0.29 | +21.6% |
| 2024-11-05 | -$0.32 | -$0.46 | -43.8% |
| 2024-08-01 | -$0.33 | -$0.28 | +15.2% |
| 2024-05-07 | -$0.54 | -$0.54 | 0.0% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 97.06% annually over 5 years — strong growth
Generating 45.01M in free cash flow
P/E of 101.18 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 68.60%
Cash machine — converts 201.06% of earnings into free cash flow
Capital efficient — spends only 0.03% of revenue on capex
Growth
Revenue Growth (5Y)
97.06%
Revenue (1Y)28.46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
7.48%
ROIC4.85%
Net Margin2.23%
Op. Margin5.52%
Safety
Debt / Equity
1.31
Current Ratio3.14
Interest Coverage1.25
Valuation
P/E Ratio
101.18
Forward P/EN/A
P/B Ratio6.12
EV/EBITDA41.20
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28.46% | Revenue Growth (3Y) | 59.09% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 97.06% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.00B | Net Income (TTM) | 22.39M |
| ROE | 7.48% | ROA | 2.08% |
| Gross Margin | 89.81% | Operating Margin | 5.52% |
| Net Margin | 2.23% | Free Cash Flow (TTM) | 45.01M |
| ROIC | 4.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.31 | Current Ratio | 3.14 |
| Interest Coverage | 1.25 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 101.18 | Forward P/E | N/A |
| P/B Ratio | 6.12 | P/S Ratio | 2.26 |
| PEG Ratio | -1.27 | Forward PEG | N/A |
| EV/EBITDA | 41.20 | Fwd EV/EBITDA | N/A |
| Forward P/S | 2.63 | Fwd Earnings Yield | N/A |
| FCF Yield | 1.99% | ||
| Market Cap | 2.27B | Enterprise Value | 2.28B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.00B | 781.37M | 396.59M | 75.42M | 66.56M |
| Net Income | 22.39M | -197.88M | -528.63M | -652.17M | -746.35M |
| EPS (Diluted) | 0.18 | -1.60 | -4.45 | -6.15 | -8.84 |
| Gross Profit | 901.55M | 663.64M | 338.08M | 69.79M | 61.36M |
| Operating Income | 55.43M | -164.98M | -517.12M | -594.61M | -536.28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.08B | 885.05M | 788.73M | 760.22M | 881.77M |
| Total Liabilities | 705.11M | 656.51M | 594.21M | 590.35M | 683.10M |
| Shareholders' Equity | 370.15M | 228.54M | 194.52M | 169.87M | 198.66M |
| Total Debt | 486.31M | 469.78M | 110.93M | 112.71M | 210.22M |
| Cash & Equivalents | 467.76M | 411.29M | 351.19M | 551.80M | 640.19M |
| Current Assets | 1.01B | 788.95M | 766.33M | 719.52M | 824.05M |
| Current Liabilities | 323.60M | 185.51M | 247.59M | 167.61M | 131.85M |